Menu

Parnell Pharmaceuticals Holdings Ltd PARNF

Full chart Compare
Set alert

Price alert · PARNF

All alert types
0.08 +0.08

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $19.26MGross Profit → Expenses: $19.26MRevenue → Cost of Revenue: $14.90MExpenses → Selling, General & Admin: $15.09MExpenses → Research & Development: $2.83MExpenses → Other Expenses: $2.77MNet Loss → Expenses: $1.42MGross Profit$19.26MNet Loss$1.42MCost of Revenue$14.90MExpenses$20.68MSelling, General & Admin$15.09MResearch & Development$2.83MOther Expenses$2.77MRevenue$34.17M

Latest period ending Dec 31, 2016 · select a line to chart its full history

PARNF annual income statement
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Jun 30, 2014FY 2013 Jun 30, 2013FY 2012 Jun 30, 2012
19.97M19.89M9.79M11.74M12.61M
10.99M12.15M3.37M6.10M8.29M
-17.86M-12.45M-5.71M715.96K3.43M
-21.69M-13.74M-17.33M-3.48M67.34K
-1.37-1.03-2.18-0.460.01
PARNF annual balance sheet
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Jun 30, 2014FY 2013 Jun 30, 2013FY 2012 Jun 30, 2012
7.12M5.67M20.80M859.71K78.29K
47.58M46.21M47.74M31.56M26.68M
39.51M25.95M10.97M29.17M20.10M
29.84M17.48M4.29M20.20M11.94M
8.06M20.25M36.78M2.39M6.58M
PARNF annual cash flow
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Jun 30, 2014FY 2013 Jun 30, 2013FY 2012 Jun 30, 2012
-12.12M-16.42M-11.46M-2.98M-3.56M
-5.08M-7.88M-482.54K0-5.21M
19.96M12.09M31.89M01.01M
-556.32K-1.73M-59.99K00
1.45M-10.15M19.94M781.41K-644.69K